3 Stocks Under $50 with Open Questions
3 Healthcare Stocks with Questionable Fundamentals
Why NeoGenomics (NEO) Stock Is Up Today
3 of Wall Street’s Favorite Stocks with Questionable Fundamentals
NeoGenomics’s (NASDAQ:NEO) Q2 CY2026: Beats On Revenue
Total revenue increased 11% YoY to $202 million Clinical services revenue grew 14%, with NGS revenue growth of 26% Company raises full-year...
NeoGenomics (NEO) Q2 Earnings Report Preview: What To Look For
1 Momentum Stock with Solid Fundamentals and 2 We Avoid
NeoGenomics, Inc. (the “Company”) (NASDAQ: NEO) , a leading provider of oncology diagnostic solutions that enable precision medicine, today announced that it has finalized a civil settlement...